Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fasting | 3 | 2020 | 267 | 0.860 |
Why?
|
| Energy Intake | 3 | 2020 | 461 | 0.790 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 205 | 0.590 |
Why?
|
| Patient Compliance | 1 | 2020 | 563 | 0.500 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2006 | 39 | 0.370 |
Why?
|
| Qc-SNARE Proteins | 1 | 2006 | 7 | 0.270 |
Why?
|
| Histidine | 1 | 2005 | 60 | 0.240 |
Why?
|
| Catheters, Indwelling | 1 | 2004 | 80 | 0.220 |
Why?
|
| Sulfadiazine | 1 | 2004 | 4 | 0.220 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2004 | 3 | 0.220 |
Why?
|
| Mycobacterium Infections | 1 | 2004 | 62 | 0.220 |
Why?
|
| Ureteral Calculi | 1 | 2004 | 13 | 0.220 |
Why?
|
| Mycobacterium | 1 | 2004 | 106 | 0.210 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 103 | 0.210 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 123 | 0.200 |
Why?
|
| Mobility Limitation | 2 | 2020 | 60 | 0.200 |
Why?
|
| Feeding Behavior | 2 | 2019 | 622 | 0.200 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 383 | 0.200 |
Why?
|
| Bacteremia | 1 | 2004 | 194 | 0.200 |
Why?
|
| Pilot Projects | 3 | 2020 | 1584 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1117 | 0.160 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 284 | 0.160 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2017 | 58 | 0.140 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2006 | 26 | 0.130 |
Why?
|
| Interleukin-6 | 1 | 2020 | 720 | 0.130 |
Why?
|
| Body Composition | 1 | 2020 | 649 | 0.130 |
Why?
|
| Self Report | 1 | 2020 | 795 | 0.120 |
Why?
|
| Age Factors | 2 | 2020 | 3140 | 0.120 |
Why?
|
| Vesicular Transport Proteins | 2 | 2006 | 84 | 0.120 |
Why?
|
| Eating | 1 | 2017 | 368 | 0.120 |
Why?
|
| Overweight | 1 | 2019 | 531 | 0.110 |
Why?
|
| Weight Loss | 1 | 2019 | 732 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1367 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 39 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 97 | 0.080 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2008 | 3 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 7055 | 0.070 |
Why?
|
| Enterotoxins | 1 | 2008 | 87 | 0.070 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 104 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2008 | 112 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 5384 | 0.070 |
Why?
|
| Travel | 1 | 2008 | 121 | 0.070 |
Why?
|
| Diarrhea | 1 | 2008 | 180 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 841 | 0.070 |
Why?
|
| Micelles | 1 | 2006 | 37 | 0.070 |
Why?
|
| Escherichia coli Proteins | 1 | 2008 | 178 | 0.070 |
Why?
|
| Aged | 3 | 2020 | 22032 | 0.070 |
Why?
|
| SNARE Proteins | 1 | 2006 | 39 | 0.070 |
Why?
|
| Static Electricity | 1 | 2006 | 116 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2008 | 300 | 0.060 |
Why?
|
| Valine | 1 | 2006 | 81 | 0.060 |
Why?
|
| Organothiophosphates | 1 | 2006 | 5 | 0.060 |
Why?
|
| Leucine | 1 | 2006 | 108 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2006 | 265 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 525 | 0.060 |
Why?
|
| Tryptophan | 1 | 2006 | 178 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 213 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 385 | 0.060 |
Why?
|
| Cytosol | 1 | 2005 | 219 | 0.060 |
Why?
|
| Humans | 11 | 2020 | 129271 | 0.060 |
Why?
|
| Endosomes | 1 | 2005 | 126 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 538 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 541 | 0.050 |
Why?
|
| Protein Transport | 1 | 2005 | 428 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2005 | 611 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 915 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2005 | 332 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2006 | 605 | 0.050 |
Why?
|
| Lipids | 1 | 2006 | 625 | 0.050 |
Why?
|
| Binding Sites | 1 | 2005 | 1250 | 0.050 |
Why?
|
| Stroke | 1 | 2010 | 1070 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 569 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2056 | 0.050 |
Why?
|
| Male | 4 | 2020 | 63517 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 2063 | 0.040 |
Why?
|
| Protein Binding | 1 | 2006 | 2120 | 0.040 |
Why?
|
| Female | 4 | 2020 | 68556 | 0.040 |
Why?
|
| Brain | 1 | 2010 | 2669 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2017 | 52 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 68 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2017 | 75 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2020 | 303 | 0.030 |
Why?
|
| Immunoassay | 1 | 2017 | 107 | 0.030 |
Why?
|
| Gait | 1 | 2019 | 278 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 867 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 641 | 0.030 |
Why?
|
| Health Status | 1 | 2019 | 754 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2515 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 2737 | 0.020 |
Why?
|
| Adult | 3 | 2010 | 35497 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6543 | 0.020 |
Why?
|
| Mexico | 1 | 2008 | 190 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 2687 | 0.020 |
Why?
|
| Middle Aged | 2 | 2008 | 31091 | 0.020 |
Why?
|
| Inositol | 1 | 2006 | 26 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 54 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1839 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 78 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2006 | 481 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 10202 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 257 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 1710 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 14461 | 0.010 |
Why?
|
| United States | 1 | 2008 | 13828 | 0.010 |
Why?
|